FDA finding on Xiaflex expected in September

xiaflex peyronies disease

Will the FDA approve the Auxilium drug Xiaflex for Peyronie’s Disease?  News is expected during the first week of September.  Xiaflex consists of an enzyme which breaks down the plaque that causes curvature of the penis.  Trial studies indicate that the drug can reduce the degree of penile curvature in Peyronie’s disease and other symptoms for men with the disease, and results have been consistent in multiple phases. Urosciences will watch the Web for the latest news on Xiaflex for Peyronie’s Disease, and keep our viewers posted.  The drug is already in use for a crippling hand condition known as Dupuytren’s contracture.

This post was written by  UroSciences, developers of the PDAD Peyronie’s Disease Assessment Device for urologists and patients.

Join Urosciences on FaceBook and Twitter.

 

 

 

Tags: , , , ,